News - Hadean Ventures

Neuro Event Labs, Nelli® officially received European MDR (Medical Device Regulation) certification as a Class IIa medical device

Great news from Neuro Event Labs Oy, as Nelli®, their AI-powered seizure detection and characterization…

TargED Biopharmaceuticals doses first participant in Phase 1 clinical trial of TGD001, a groundbreaking thrombolytic…

VALENCIA, Spain, Oct. 18, 2024 /PRNewswire/ — ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on…

Transition into clinical-stage development marks a significant corporate and R&D milestone. Munich, Germany, October 17,…

Alex Therapeutics has signed an exclusive agreement with Navamedic for the development of a Companion…

Attgeno AB today announces positive data from the company’s Phase IIa study, evaluating the effects…

Oncoinvent Receives FDA Fast Track Designation for Radspherin® as Treatment for Peritoneal Carcinomatosis from Ovarian…

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease Bagsværd, Denmark, and…

ARTHEx Biotech Receives IND Clearance from FDA to Initiate the Phase I-IIa...

Hadean Ventures announces oversubscribed final close of Hadean Capital II